MannKind Corporation · 4 days ago
Accounting Intern
MannKind Corporation is a biopharmaceutical company focused on transforming chronic disease care. They are offering a Summer Internship Program where interns will engage in financial analysis and support various financial processes, gaining hands-on experience in the biotech industry.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Conducting financial analysis to support decision making
Assisting in the month-end close activities and preparation of financial statements (P&L, Balance Sheet, and Cash Flow) and other internal reports
Support the Form 10-Q process through peer benchmarking, analysis of new FASB accounting standards and tie out procedures
Manage the implementation of SOX workflow within Floqast
Reviewing GL accounts and proposing requests for new accounts and roll-up of accounts
Perform data analysis to identify trends and potential issues
Participate in the implementation of financial systems and processes
Assist with ad-hoc projects as needed/assigned
Qualification
Required
Pursuing a bachelor's degree in business, accounting, or finance
Must currently have a 3.0 GPA or equivalent
Must be able to work 40 hours per week for the full 12 weeks (no vacation weeks)
Must have completed 2 years of college
A reliable commute or the intention to find temporary housing before starting the internship is required
At this time, we are only able to consider candidates who do not require visa sponsorship, including those with a student visa
Preferred
Preferably within 1-2 years of graduation
Strong analytical, interpersonal, organizational, and problem-solving skills
Excellent attention to detail and ability to work independently
Proficiency in Microsoft Excel and other financial software programs (Power Bl and TM1 bonus)
Strong written and verbal communication skills
Self-motivated and demonstrated learning agility
You take the initiative to identify opportunities for improvement and act on them without needing constant direction
You are open to constructive criticism and use it to improve performance and grow professionally
Company
MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions.
Funding
Current Stage
Public CompanyTotal Funding
$475MKey Investors
Blackstone GroupDeerfield Capital Management
2025-08-06Post Ipo Debt· $75M
2021-03-02Post Ipo Debt· $200M
2018-12-01Post Ipo Equity· $40M
Recent News
2026-01-15
2026-01-09
GlobeNewswire
2025-12-24
Company data provided by crunchbase